Tasquinimod
CAS No. 254964-60-8
Tasquinimod ( ABR-215050;ABR215050;ABR 215050 )
Catalog No. M13764 CAS No. 254964-60-8
An orally active antiangiogenic agent with anti-prostate cancer activity, an allosteric modulator of HDAC4 with Kd of 10-30 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 58 | In Stock |
|
5MG | 86 | In Stock |
|
10MG | 123 | In Stock |
|
25MG | 207 | In Stock |
|
50MG | 306 | In Stock |
|
100MG | 468 | In Stock |
|
500MG | 1044 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTasquinimod
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn orally active antiangiogenic agent with anti-prostate cancer activity, an allosteric modulator of HDAC4 with Kd of 10-30 nM.
-
DescriptionAn orally active antiangiogenic agent with anti-prostate cancer activity, an allosteric modulator of HDAC4 with Kd of 10-30 nM; inhibits colocalization of N-CoR/HDAC3, thereby inhibiting deacetylation of histones and HDAC4 client transcription factors, such as HIF-1α.Prostate cancer Phase 3 Clinical
-
SynonymsABR-215050;ABR215050;ABR 215050
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC4
-
Research AreaCancer
-
IndicationProstate Cancer
Chemical Information
-
CAS Number254964-60-8
-
Formula Weight406.36
-
Molecular FormulaC20H17F3N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 42 mg/mL
-
SMILESO=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2OC)N(C)C3=CC=C(C(F)(F)F)C=C3
-
Chemical Name3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Isaacs JT, et al. Prostate. 2006 Dec 1;66(16):1768-78.
2. Olsson A, et al. Mol Cancer. 2010 May 17;9:107.
3. Dalrymple SL, et al. Prostate. 2012 May 1;72(6):638-48.
4. Isaacs JT, et al. Cancer Res. 2013 Feb 15;73(4):1386-99.
2. Olsson A, et al. Mol Cancer. 2010 May 17;9:107.
3. Dalrymple SL, et al. Prostate. 2012 May 1;72(6):638-48.
4. Isaacs JT, et al. Cancer Res. 2013 Feb 15;73(4):1386-99.
molnova catalog
related products
-
SALL4 peptide FFW
SALL4 peptide FFW (RRKFAKFQWI, FFW peptide) is a potent therapeutic SALL4 peptide antagonist of SALL4-NURD.
-
SBHA
SBHA (suberohydroxamic acid) is a Histone deacetylase (HDAC) inhibitor. HDAC is required for transcriptional modulation, cell cycle regulation and development.
-
Givinostat
Givinostat hydrochloride monohydrate is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.